← Browse by Condition
Medical Condition

respiratory disease

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for respiratory disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — respiratory disease Clinical Trials

How many clinical trials are currently recruiting for respiratory disease?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for respiratory disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for respiratory disease?
respiratory disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a respiratory disease clinical trial?
Eligibility criteria for respiratory disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Seoul National University Hospital 1 trial
Hacettepe University 1 trial
NHS Greater Glasgow and Clyde 1 trial
Chinese Academy of Sciences 1 trial

Recruiting Clinical Trials

NCT06726226
Recruiting
Extremely Preterm Respiratory Outcome Cohort
Enrollment
600 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT06796894
Recruiting
Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Hacettepe University
View Trial →
NCT06271213
Recruiting
The Gut-Lung Axis and Respiratory Illness in Children
Enrollment
150 pts
Location
United Kingdom
Sponsor
NHS Greater Glasgow and Clyde
View Trial →
NCT07585214
Recruiting
Prospective Multicenter Screening for Thoracic Disease Via Radiography
Enrollment
300,000 pts
Location
China
Sponsor
Chinese Academy of Sciences
View Trial →

Related Conditions

infant premature (1) asthma (1) fragility (1) respiration disorders (1) asthma in children (1) wheezing (1) gastro intestinal disorder (1) healthy (1) pulmonary diseases (1) esophageal diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology